Lundbeck Leads $50m Fund Raise For CRISPR Microbiome StartUp

 
• By Jo Shorthouse

A Danish company with a novel approach to gene editing for antibacterials has raised $50m in a series A round, using the cash injection to advance its ambition to be testing drug candidates in humans by 2021.

Watch repairs
Precision is the order of the day for SNIPR Biome • Source: Shutterstock

More from Financing

More from Business